img

Global Vascular Endothelial Growth Factor B Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Vascular Endothelial Growth Factor B Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Vascular Endothelial Growth Factor B report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Vascular Endothelial Growth Factor B market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Rectal Cancer and Retinal Vein Occlusion are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Vascular Endothelial Growth Factor B industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Vascular Endothelial Growth Factor B key manufacturers include Alteogen Inc, CSL Ltd, Eli Lilly and Company, Formycon AG and Regeneron Pharmaceuticals Inc, etc. Alteogen Inc, CSL Ltd, Eli Lilly and Company are top 3 players and held % sales share in total in 2022.
Vascular Endothelial Growth Factor B can be divided into Aflibercept, Aflibercept Biosimilar, CSL-346 and Others, etc. Aflibercept is the mainstream product in the market, accounting for % sales share globally in 2022.
Vascular Endothelial Growth Factor B is widely used in various fields, such as Rectal Cancer, Retinal Vein Occlusion, Diabetic Nephropathy and Others, etc. Rectal Cancer provides greatest supports to the Vascular Endothelial Growth Factor B industry development. In 2022, global % sales of Vascular Endothelial Growth Factor B went into Rectal Cancer filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Vascular Endothelial Growth Factor B market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Alteogen Inc
CSL Ltd
Eli Lilly and Company
Formycon AG
Regeneron Pharmaceuticals Inc
Segment by Type
Aflibercept
Aflibercept Biosimilar
CSL-346
Others

Segment by Application


Rectal Cancer
Retinal Vein Occlusion
Diabetic Nephropathy
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Vascular Endothelial Growth Factor B market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Vascular Endothelial Growth Factor B, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Vascular Endothelial Growth Factor B industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Vascular Endothelial Growth Factor B in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Vascular Endothelial Growth Factor B introduction, etc. Vascular Endothelial Growth Factor B Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Vascular Endothelial Growth Factor B market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Vascular Endothelial Growth Factor B Market Overview
1.1 Vascular Endothelial Growth Factor B Product Overview
1.2 Vascular Endothelial Growth Factor B Market Segment by Type
1.2.1 Aflibercept
1.2.2 Aflibercept Biosimilar
1.2.3 CSL-346
1.2.4 Others
1.3 Global Vascular Endothelial Growth Factor B Market Size by Type
1.3.1 Global Vascular Endothelial Growth Factor B Market Size Overview by Type (2018-2034)
1.3.2 Global Vascular Endothelial Growth Factor B Historic Market Size Review by Type (2018-2024)
1.3.3 Global Vascular Endothelial Growth Factor B Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Vascular Endothelial Growth Factor B Sales Breakdown by Type (2018-2024)
1.4.2 Europe Vascular Endothelial Growth Factor B Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Vascular Endothelial Growth Factor B Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Vascular Endothelial Growth Factor B Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Vascular Endothelial Growth Factor B Sales Breakdown by Type (2018-2024)
2 Global Vascular Endothelial Growth Factor B Market Competition by Company
2.1 Global Top Players by Vascular Endothelial Growth Factor B Sales (2018-2024)
2.2 Global Top Players by Vascular Endothelial Growth Factor B Revenue (2018-2024)
2.3 Global Top Players by Vascular Endothelial Growth Factor B Price (2018-2024)
2.4 Global Top Manufacturers Vascular Endothelial Growth Factor B Manufacturing Base Distribution, Sales Area, Product Type
2.5 Vascular Endothelial Growth Factor B Market Competitive Situation and Trends
2.5.1 Vascular Endothelial Growth Factor B Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Vascular Endothelial Growth Factor B Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vascular Endothelial Growth Factor B as of 2022)
2.7 Date of Key Manufacturers Enter into Vascular Endothelial Growth Factor B Market
2.8 Key Manufacturers Vascular Endothelial Growth Factor B Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Vascular Endothelial Growth Factor B Status and Outlook by Region
3.1 Global Vascular Endothelial Growth Factor B Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Vascular Endothelial Growth Factor B Historic Market Size by Region
3.2.1 Global Vascular Endothelial Growth Factor B Sales in Volume by Region (2018-2024)
3.2.2 Global Vascular Endothelial Growth Factor B Sales in Value by Region (2018-2024)
3.2.3 Global Vascular Endothelial Growth Factor B Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Vascular Endothelial Growth Factor B Forecasted Market Size by Region
3.3.1 Global Vascular Endothelial Growth Factor B Sales in Volume by Region (2024-2034)
3.3.2 Global Vascular Endothelial Growth Factor B Sales in Value by Region (2024-2034)
3.3.3 Global Vascular Endothelial Growth Factor B Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Vascular Endothelial Growth Factor B by Application
4.1 Vascular Endothelial Growth Factor B Market Segment by Application
4.1.1 Rectal Cancer
4.1.2 Retinal Vein Occlusion
4.1.3 Diabetic Nephropathy
4.1.4 Others
4.2 Global Vascular Endothelial Growth Factor B Market Size by Application
4.2.1 Global Vascular Endothelial Growth Factor B Market Size Overview by Application (2018-2034)
4.2.2 Global Vascular Endothelial Growth Factor B Historic Market Size Review by Application (2018-2024)
4.2.3 Global Vascular Endothelial Growth Factor B Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Vascular Endothelial Growth Factor B Sales Breakdown by Application (2018-2024)
4.3.2 Europe Vascular Endothelial Growth Factor B Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Vascular Endothelial Growth Factor B Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Vascular Endothelial Growth Factor B Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Vascular Endothelial Growth Factor B Sales Breakdown by Application (2018-2024)
5 North America Vascular Endothelial Growth Factor B by Country
5.1 North America Vascular Endothelial Growth Factor B Historic Market Size by Country
5.1.1 North America Vascular Endothelial Growth Factor B Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Vascular Endothelial Growth Factor B Sales in Volume by Country (2018-2024)
5.1.3 North America Vascular Endothelial Growth Factor B Sales in Value by Country (2018-2024)
5.2 North America Vascular Endothelial Growth Factor B Forecasted Market Size by Country
5.2.1 North America Vascular Endothelial Growth Factor B Sales in Volume by Country (2024-2034)
5.2.2 North America Vascular Endothelial Growth Factor B Sales in Value by Country (2024-2034)
6 Europe Vascular Endothelial Growth Factor B by Country
6.1 Europe Vascular Endothelial Growth Factor B Historic Market Size by Country
6.1.1 Europe Vascular Endothelial Growth Factor B Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Vascular Endothelial Growth Factor B Sales in Volume by Country (2018-2024)
6.1.3 Europe Vascular Endothelial Growth Factor B Sales in Value by Country (2018-2024)
6.2 Europe Vascular Endothelial Growth Factor B Forecasted Market Size by Country
6.2.1 Europe Vascular Endothelial Growth Factor B Sales in Volume by Country (2024-2034)
6.2.2 Europe Vascular Endothelial Growth Factor B Sales in Value by Country (2024-2034)
7 Asia-Pacific Vascular Endothelial Growth Factor B by Region
7.1 Asia-Pacific Vascular Endothelial Growth Factor B Historic Market Size by Region
7.1.1 Asia-Pacific Vascular Endothelial Growth Factor B Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Vascular Endothelial Growth Factor B Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Vascular Endothelial Growth Factor B Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Vascular Endothelial Growth Factor B Forecasted Market Size by Region
7.2.1 Asia-Pacific Vascular Endothelial Growth Factor B Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Vascular Endothelial Growth Factor B Sales in Value by Region (2024-2034)
8 Latin America Vascular Endothelial Growth Factor B by Country
8.1 Latin America Vascular Endothelial Growth Factor B Historic Market Size by Country
8.1.1 Latin America Vascular Endothelial Growth Factor B Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Vascular Endothelial Growth Factor B Sales in Volume by Country (2018-2024)
8.1.3 Latin America Vascular Endothelial Growth Factor B Sales in Value by Country (2018-2024)
8.2 Latin America Vascular Endothelial Growth Factor B Forecasted Market Size by Country
8.2.1 Latin America Vascular Endothelial Growth Factor B Sales in Volume by Country (2024-2034)
8.2.2 Latin America Vascular Endothelial Growth Factor B Sales in Value by Country (2024-2034)
9 Middle East and Africa Vascular Endothelial Growth Factor B by Country
9.1 Middle East and Africa Vascular Endothelial Growth Factor B Historic Market Size by Country
9.1.1 Middle East and Africa Vascular Endothelial Growth Factor B Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Vascular Endothelial Growth Factor B Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Vascular Endothelial Growth Factor B Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Vascular Endothelial Growth Factor B Forecasted Market Size by Country
9.2.1 Middle East and Africa Vascular Endothelial Growth Factor B Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Vascular Endothelial Growth Factor B Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Alteogen Inc
10.1.1 Alteogen Inc Company Information
10.1.2 Alteogen Inc Introduction and Business Overview
10.1.3 Alteogen Inc Vascular Endothelial Growth Factor B Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Alteogen Inc Vascular Endothelial Growth Factor B Products Offered
10.1.5 Alteogen Inc Recent Development
10.2 CSL Ltd
10.2.1 CSL Ltd Company Information
10.2.2 CSL Ltd Introduction and Business Overview
10.2.3 CSL Ltd Vascular Endothelial Growth Factor B Sales, Revenue and Gross Margin (2018-2024)
10.2.4 CSL Ltd Vascular Endothelial Growth Factor B Products Offered
10.2.5 CSL Ltd Recent Development
10.3 Eli Lilly and Company
10.3.1 Eli Lilly and Company Company Information
10.3.2 Eli Lilly and Company Introduction and Business Overview
10.3.3 Eli Lilly and Company Vascular Endothelial Growth Factor B Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Eli Lilly and Company Vascular Endothelial Growth Factor B Products Offered
10.3.5 Eli Lilly and Company Recent Development
10.4 Formycon AG
10.4.1 Formycon AG Company Information
10.4.2 Formycon AG Introduction and Business Overview
10.4.3 Formycon AG Vascular Endothelial Growth Factor B Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Formycon AG Vascular Endothelial Growth Factor B Products Offered
10.4.5 Formycon AG Recent Development
10.5 Regeneron Pharmaceuticals Inc
10.5.1 Regeneron Pharmaceuticals Inc Company Information
10.5.2 Regeneron Pharmaceuticals Inc Introduction and Business Overview
10.5.3 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Products Offered
10.5.5 Regeneron Pharmaceuticals Inc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Vascular Endothelial Growth Factor B Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Vascular Endothelial Growth Factor B Industrial Chain Analysis
11.4 Vascular Endothelial Growth Factor B Market Dynamics
11.4.1 Vascular Endothelial Growth Factor B Industry Trends
11.4.2 Vascular Endothelial Growth Factor B Market Drivers
11.4.3 Vascular Endothelial Growth Factor B Market Challenges
11.4.4 Vascular Endothelial Growth Factor B Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Vascular Endothelial Growth Factor B Distributors
12.3 Vascular Endothelial Growth Factor B Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Aflibercept
Table 2. Major Company of Aflibercept Biosimilar
Table 3. Major Company of CSL-346
Table 4. Major Company of Others
Table 5. Global Vascular Endothelial Growth Factor B Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Vascular Endothelial Growth Factor B Sales by Type (2018-2024) & (K Pcs)
Table 7. Global Vascular Endothelial Growth Factor B Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Vascular Endothelial Growth Factor B Sales by Type (2018-2024) & (US& Million)
Table 9. Global Vascular Endothelial Growth Factor B Market Share in Value by Type (2018-2024)
Table 10. Global Vascular Endothelial Growth Factor B Price by Type (2018-2024) & (USD/Pcs)
Table 11. Global Vascular Endothelial Growth Factor B Sales by Type (2024-2034) & (K Pcs)
Table 12. Global Vascular Endothelial Growth Factor B Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Vascular Endothelial Growth Factor B Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Vascular Endothelial Growth Factor B Sales Market Share in Value by Type (2024-2034)
Table 15. Global Vascular Endothelial Growth Factor B Price by Type (2024-2034) & (USD/Pcs)
Table 16. North America Vascular Endothelial Growth Factor B Sales by Type (2018-2024) & (K Pcs)
Table 17. North America Vascular Endothelial Growth Factor B Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Vascular Endothelial Growth Factor B Sales (K Pcs) by Type (2018-2024)
Table 19. Europe Vascular Endothelial Growth Factor B Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Vascular Endothelial Growth Factor B Sales (K Pcs) by Type (2018-2024)
Table 21. Asia-Pacific Vascular Endothelial Growth Factor B Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Vascular Endothelial Growth Factor B Sales (K Pcs) by Type (2018-2024)
Table 23. Latin America Vascular Endothelial Growth Factor B Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Vascular Endothelial Growth Factor B Sales (K Pcs) by Type (2018-2024)
Table 25. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Vascular Endothelial Growth Factor B Sales by Company (2018-2024) & (K Pcs)
Table 27. Global Vascular Endothelial Growth Factor B Sales Share by Company (2018-2024)
Table 28. Global Vascular Endothelial Growth Factor B Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Vascular Endothelial Growth Factor B Revenue Share by Company (2018-2024)
Table 30. Global Market Vascular Endothelial Growth Factor B Price by Company (2018-2024) & (USD/Pcs)
Table 31. Global Vascular Endothelial Growth Factor B Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Vascular Endothelial Growth Factor B Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vascular Endothelial Growth Factor B as of 2022)
Table 34. Date of Key Manufacturers Enter into Vascular Endothelial Growth Factor B Market
Table 35. Key Manufacturers Vascular Endothelial Growth Factor B Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Vascular Endothelial Growth Factor B Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Vascular Endothelial Growth Factor B Sales by Region (2018-2024) & (K Pcs)
Table 39. Global Vascular Endothelial Growth Factor B Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Vascular Endothelial Growth Factor B Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Vascular Endothelial Growth Factor B Sales Market Share in Value by Region (2018-2024)
Table 42. Global Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 43. Global Vascular Endothelial Growth Factor B Sales by Region (2024-2034) & (K Pcs)
Table 44. Global Vascular Endothelial Growth Factor B Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Vascular Endothelial Growth Factor B Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Vascular Endothelial Growth Factor B Sales Market Share in Value by Region (2024-2034)
Table 47. Global Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 48. Global Vascular Endothelial Growth Factor B Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Vascular Endothelial Growth Factor B Sales by Application (2018-2024) & (K Pcs)
Table 50. Global Vascular Endothelial Growth Factor B Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Vascular Endothelial Growth Factor B Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Vascular Endothelial Growth Factor B Sales Market Share in Value by Application (2018-2024)
Table 53. Global Vascular Endothelial Growth Factor B Price by Application (2018-2024) & (USD/Pcs)
Table 54. Global Vascular Endothelial Growth Factor B Sales by Application (2024-2034) & (K Pcs)
Table 55. Global Vascular Endothelial Growth Factor B Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Vascular Endothelial Growth Factor B Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Vascular Endothelial Growth Factor B Sales Market Share in Value by Application (2024-2034)
Table 58. Global Vascular Endothelial Growth Factor B Price by Application (2024-2034) & (USD/Pcs)
Table 59. North America Vascular Endothelial Growth Factor B Sales by Application (2018-2024) (K Pcs)
Table 60. North America Vascular Endothelial Growth Factor B Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Vascular Endothelial Growth Factor B Sales by Application (2018-2024) (K Pcs)
Table 62. Europe Vascular Endothelial Growth Factor B Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Vascular Endothelial Growth Factor B Sales by Application (2018-2024) (K Pcs)
Table 64. Asia-Pacific Vascular Endothelial Growth Factor B Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Vascular Endothelial Growth Factor B Sales by Application (2018-2024) (K Pcs)
Table 66. Latin America Vascular Endothelial Growth Factor B Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Application (2018-2024) (K Pcs)
Table 68. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Vascular Endothelial Growth Factor B Sales by Country (2018-2024) & (K Pcs)
Table 70. North America Vascular Endothelial Growth Factor B Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Vascular Endothelial Growth Factor B Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Vascular Endothelial Growth Factor B Sales Market Share in Value by Country (2018-2024)
Table 73. North America Vascular Endothelial Growth Factor B Sales by Country (2024-2034) & (K Pcs)
Table 74. North America Vascular Endothelial Growth Factor B Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Vascular Endothelial Growth Factor B Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Vascular Endothelial Growth Factor B Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Vascular Endothelial Growth Factor B Sales by Country (2018-2024) & (K Pcs)
Table 78. Europe Vascular Endothelial Growth Factor B Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Vascular Endothelial Growth Factor B Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Vascular Endothelial Growth Factor B Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Vascular Endothelial Growth Factor B Sales by Country (2024-2034) & (K Pcs)
Table 82. Europe Vascular Endothelial Growth Factor B Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Vascular Endothelial Growth Factor B Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Vascular Endothelial Growth Factor B Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Vascular Endothelial Growth Factor B Sales by Region (2018-2024) & (K Pcs)
Table 86. Asia-Pacific Vascular Endothelial Growth Factor B Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Vascular Endothelial Growth Factor B Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Vascular Endothelial Growth Factor B Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Vascular Endothelial Growth Factor B Sales by Region (2024-2034) & (K Pcs)
Table 90. Asia-Pacific Vascular Endothelial Growth Factor B Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Vascular Endothelial Growth Factor B Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Vascular Endothelial Growth Factor B Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Vascular Endothelial Growth Factor B Sales by Country (2018-2024) & (K Pcs)
Table 94. Latin America Vascular Endothelial Growth Factor B Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Vascular Endothelial Growth Factor B Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Vascular Endothelial Growth Factor B Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Vascular Endothelial Growth Factor B Sales by Country (2024-2034) & (K Pcs)
Table 98. Latin America Vascular Endothelial Growth Factor B Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Vascular Endothelial Growth Factor B Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Vascular Endothelial Growth Factor B Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Country (2018-2024) & (K Pcs)
Table 102. Middle East and Africa Vascular Endothelial Growth Factor B Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Vascular Endothelial Growth Factor B Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Country (2024-2034) & (K Pcs)
Table 106. Middle East and Africa Vascular Endothelial Growth Factor B Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Vascular Endothelial Growth Factor B Sales Market Share in Value by Country (2024-2034)
Table 109. Alteogen Inc Company Information
Table 110. Alteogen Inc Introduction and Business Overview
Table 111. Alteogen Inc Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 112. Alteogen Inc Vascular Endothelial Growth Factor B Product
Table 113. Alteogen Inc Recent Development
Table 114. CSL Ltd Company Information
Table 115. CSL Ltd Introduction and Business Overview
Table 116. CSL Ltd Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 117. CSL Ltd Vascular Endothelial Growth Factor B Product
Table 118. CSL Ltd Recent Development
Table 119. Eli Lilly and Company Company Information
Table 120. Eli Lilly and Company Introduction and Business Overview
Table 121. Eli Lilly and Company Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 122. Eli Lilly and Company Vascular Endothelial Growth Factor B Product
Table 123. Eli Lilly and Company Recent Development
Table 124. Formycon AG Company Information
Table 125. Formycon AG Introduction and Business Overview
Table 126. Formycon AG Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 127. Formycon AG Vascular Endothelial Growth Factor B Product
Table 128. Formycon AG Recent Development
Table 129. Regeneron Pharmaceuticals Inc Company Information
Table 130. Regeneron Pharmaceuticals Inc Introduction and Business Overview
Table 131. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 132. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product
Table 133. Regeneron Pharmaceuticals Inc Recent Development
Table 134. Key Raw Materials Lists
Table 135. Raw Materials Key Suppliers Lists
Table 136. Vascular Endothelial Growth Factor B Market Trends
Table 137. Vascular Endothelial Growth Factor B Market Drivers
Table 138. Vascular Endothelial Growth Factor B Market Challenges
Table 139. Vascular Endothelial Growth Factor B Market Restraints
Table 140. Vascular Endothelial Growth Factor B Distributors List
Table 141. Vascular Endothelial Growth Factor B Downstream Customers
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Vascular Endothelial Growth Factor B Product Picture
Figure 2. Global Vascular Endothelial Growth Factor B Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Vascular Endothelial Growth Factor B Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Vascular Endothelial Growth Factor B Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Aflibercept
Figure 6. Global Aflibercept Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Aflibercept Biosimilar
Figure 8. Global Aflibercept Biosimilar Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of CSL-346
Figure 10. Global CSL-346 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Global Vascular Endothelial Growth Factor B Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Vascular Endothelial Growth Factor B Sales Market Share by Type in 2022 & 2034
Figure 15. North America Vascular Endothelial Growth Factor B Sales Market Share in Volume by Type in 2022
Figure 16. North America Vascular Endothelial Growth Factor B Sales Market Share in Value by Type in 2022
Figure 17. Europe Vascular Endothelial Growth Factor B Sales Market Share in Volume by Type in 2022
Figure 18. Europe Vascular Endothelial Growth Factor B Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Vascular Endothelial Growth Factor B Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Vascular Endothelial Growth Factor B Sales Market Share in Value by Type in 2022
Figure 21. Latin America Vascular Endothelial Growth Factor B Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Vascular Endothelial Growth Factor B Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Vascular Endothelial Growth Factor B Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Vascular Endothelial Growth Factor B Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Vascular Endothelial Growth Factor B Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Vascular Endothelial Growth Factor B Revenue in 2022
Figure 27. Vascular Endothelial Growth Factor B Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Rectal Cancer
Figure 29. Global Rectal Cancer Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Product Picture of Retinal Vein Occlusion
Figure 31. Global Retinal Vein Occlusion Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Diabetic Nephropathy
Figure 33. Global Diabetic Nephropathy Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Global Vascular Endothelial Growth Factor B Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Vascular Endothelial Growth Factor B Sales Market Share by Application in 2022 & 2034
Figure 38. North America Vascular Endothelial Growth Factor B Sales Market Share in Volume by Application in 2022
Figure 39. North America Vascular Endothelial Growth Factor B Sales Market Share in Value by Application in 2022
Figure 40. Europe Vascular Endothelial Growth Factor B Sales Market Share in Volume by Application in 2022
Figure 41. Europe Vascular Endothelial Growth Factor B Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Vascular Endothelial Growth Factor B Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Vascular Endothelial Growth Factor B Sales Market Share in Value by Application in 2022
Figure 44. Latin America Vascular Endothelial Growth Factor B Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Vascular Endothelial Growth Factor B Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Vascular Endothelial Growth Factor B Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Vascular Endothelial Growth Factor B Manufacturing Cost Structure
Figure 49. Vascular Endothelial Growth Factor B Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries